Page last updated: 2024-09-05

anemodeanin a and Androgen-Independent Prostatic Cancer

anemodeanin a has been researched along with Androgen-Independent Prostatic Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bai, S; Dong, Y; Hu, C; Lyu, J; Xia, H; Yu, X; Zhan, Y; Zhang, BY; Zhao, L	1

Other Studies

1 other study(ies) available for anemodeanin a and Androgen-Independent Prostatic Cancer

Article	Year
Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer. Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; RNA Splicing; Saponins	2019

Article

Year

Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.

Journal of cellular and molecular medicine, 2019, Volume: 23, Issue:5

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Docetaxel; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; PC-3 Cells; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; RNA Splicing; Saponins

2019